Laboratory Corp Of America Holdings

Labcorp Holdings Inc. (NYSE: LH) is a global provider of innovative and comprehensive laboratory services, operating through two segments: Diagnostics Laboratories and Biopharma Laboratory Services. The Diagnostics Laboratories segment provides a broad range of clinical laboratory tests used by physicians and other healthcare providers to detect, diagnose, and monitor disease, including routine testing, specialty testing in areas such as oncology, genetics, and women's health, and consumer health offerings. The Biopharma Laboratory Services segment supports pharmaceutical and biotechnology companies through central laboratory services and early development services for clinical trials. The company serves clients in approximately 100 countries, employs nearly 71,000 people, and supported the development of more than 85% of the new drugs and therapeutic products approved by the FDA in 2025. Labcorp performs more than 750 million tests annually and continues to invest in technology, AI-powered consumer apps, specialty testing, and strategic acquisitions to expand its market presence. Updated Jul 30, 2026